• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗氧化剂补充与 Graves 病患者的血脂:对 LDL-胆固醇的影响。

Antioxidant supplementation and serum lipids in patients with Graves' disease: effect on LDL-cholesterol.

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia.

出版信息

Acta Pharm. 2012 Mar;62(1):115-22. doi: 10.2478/v10007-012-0005-2.

DOI:10.2478/v10007-012-0005-2
PMID:22472454
Abstract

The effect of supplementation with a fixed combination of antioxidants (beta-carotene, selenium, vitamins C and E) on serum lipids was monitored in patients with newly detected Graves' disease. Measurements were made prior to the commencement of therapy and after 30 and 60 days. Patients were randomized into two groups. Test group comprised patients who received antioxidant supplementation in addition to methimazole, while patients treated with methimazole only were in the control group. The concentration of total and HDL-cholesterol increased significantly in test and control groups (p < 0.05) but these groups did not differ significantly. Concentration of LDL-cholesterol increased significantly in the test group only (p < 0.005) and was significantly different from the control group 60 days after the commencement of therapy (p < 0.005). Significant increase in the LDL-cholesterol concentration in the test group requires further investigations.

摘要

补充抗氧化剂(β-胡萝卜素、硒、维生素 C 和 E)固定混合剂对新诊断的格雷夫斯病患者的血清脂质的影响进行了监测。在开始治疗前和 30 天后和 60 天后进行了测量。患者被随机分为两组。实验组患者除接受甲巯咪唑外还接受抗氧化剂补充治疗,而仅接受甲巯咪唑治疗的患者为对照组。实验组和对照组的总胆固醇和高密度脂蛋白胆固醇浓度均显著升高(p < 0.05),但两组之间无显著差异。仅实验组的 LDL-胆固醇浓度显著升高(p < 0.005),并且在治疗开始后 60 天与对照组有显著差异(p < 0.005)。实验组 LDL-胆固醇浓度的显著升高需要进一步研究。

相似文献

1
Antioxidant supplementation and serum lipids in patients with Graves' disease: effect on LDL-cholesterol.抗氧化剂补充与 Graves 病患者的血脂:对 LDL-胆固醇的影响。
Acta Pharm. 2012 Mar;62(1):115-22. doi: 10.2478/v10007-012-0005-2.
2
Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium.
Clin Chim Acta. 2004 Mar;341(1-2):55-63. doi: 10.1016/j.cccn.2003.10.028.
3
Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters.补充抗氧化剂治疗格雷夫斯病:对细胞外抗氧化参数的影响。
Acta Pharm. 2004 Jun;54(2):79-89.
4
The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease.抗氧化剂补充对格雷夫斯病患者红细胞中超氧化物歧化酶活性、铜和锌水平以及总抗氧化状态的影响。
Clin Chem Lab Med. 2005;43(4):383-8. doi: 10.1515/CCLM.2005.069.
5
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.Graves 病所致甲状腺功能亢进症患者抗甲状腺药物治疗中短期碘化物补充的益处。
Clin Endocrinol (Oxf). 2010 Jun;72(6):845-50. doi: 10.1111/j.1365-2265.2009.03745.x. Epub 2009 Nov 11.
6
[Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].[甲状腺素对预防抗甲状腺药物治疗的格雷夫斯病复发的作用]
Zhonghua Yi Xue Za Zhi. 2001 Mar 10;81(5):274-5.
7
Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.甲巯咪唑对格雷夫斯病甲状腺功能亢进症诱导的氧化应激的保护作用。
Endocr Regul. 2000 Jun;34(2):83-9.
8
Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial.维生素E、维生素C、维生素A及水果在冠心病中抗氧化功效的比较:一项对照试验。
J Assoc Physicians India. 2001 Mar;49:327-31.
9
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.活动性格雷夫斯病患者血清中γ干扰素诱导的α趋化因子CXCL10水平,以及甲巯咪唑治疗和甲状腺切除术对其的调节作用。
Br J Surg. 2006 Oct;93(10):1226-31. doi: 10.1002/bjs.5401.
10
Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels.抗氧化剂与甲巯咪唑治疗格雷夫斯病:对尿丙二醛水平的影响
Clin Chim Acta. 2005 Feb;352(1-2):115-20. doi: 10.1016/j.cccn.2004.08.020.

引用本文的文献

1
Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life.在格雷夫斯病中,在甲巯咪唑治疗基础上加用左旋肉碱和硒:一项关于甲状腺标志物和生活质量的前瞻性随机试验。
Nutrients. 2025 Aug 20;17(16):2693. doi: 10.3390/nu17162693.
2
Evaluation of Serum CTRP-4 and CTRP-12 Levels in Hashimoto's Thyroiditis Patients: A Comparative Analysis with a Control Group and Their Correlation with Biochemical Factors.桥本甲状腺炎患者血清CTRP - 4和CTRP - 12水平的评估:与对照组的比较分析及其与生化因子的相关性
Iran J Pathol. 2025;20(1):42-48. doi: 10.30699/ijp.2024.2025001.3276. Epub 2025 Jan 10.
3
The interplay between vitamin C and thyroid.
维生素 C 与甲状腺的相互作用。
Endocrinol Diabetes Metab. 2023 Jul;6(4):e432. doi: 10.1002/edm2.432. Epub 2023 May 29.
4
Selenium and thyroid diseases.硒与甲状腺疾病。
Front Endocrinol (Lausanne). 2023 Mar 24;14:1133000. doi: 10.3389/fendo.2023.1133000. eCollection 2023.
5
Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.硒在 Graves 甲亢和眼病治疗中的应用。
Front Endocrinol (Lausanne). 2021 Jan 26;11:608428. doi: 10.3389/fendo.2020.608428. eCollection 2020.
6
Oxidative Stress in Graves Disease and Graves Orbitopathy.格雷夫斯病和格雷夫斯眼眶病中的氧化应激
Eur Thyroid J. 2020 Dec;9(Suppl 1):40-50. doi: 10.1159/000509615. Epub 2020 Nov 20.
7
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.硒对甲巯咪唑治疗格雷夫斯病所致甲状腺功能亢进症短期控制的影响:一项随机临床试验的结果
J Endocrinol Invest. 2017 Mar;40(3):281-287. doi: 10.1007/s40618-016-0559-9. Epub 2016 Oct 12.